Insulin | Concentration | Form | Delivery | Cost* |
---|---|---|---|---|
Rapid acting | ||||
Aspart (Novolog) | U-100 | Analogue | Pen or vial | $550 (5 pens) $300 (1 vial) |
Glulisine (Apidra) | U-100 | Analogue | Pen or vial | $400 (5 pens) $185 (1 vial) |
Lispro (Humalog) | U-100 | Analogue | Pen or vial | $325 (5 pens) $175 (1 vial) |
Lispro | U-200 | Analogue | Pen | $260 (2 pens†) |
Human (Afrezza) | 4-, 8-, 12-unit cartridges‡ | Human | Inhaler | $270 (90 cartridges) |
Short acting | ||||
Regular (Humulin R) | U-100 | Human | Vial | $100 (1 vial) |
Intermediate acting | ||||
Isophane (NPH; Humulin N) | U-100 | Human | Pen or vial | $290 (5 pens) $50 (1 vial) |
Long acting | ||||
Detemir (Levemir) | U-100 | Analogue | Pen or vial | $485 (5 pens) $300 (1 vial) |
Glargine (Lantus, Basaglar) | U-100 | Analogue | Pen or vial | $330 (5 pens, Lantus or Basaglar) $260 (1 vial, Lantus) |
Glargine (Toujeo Solostar) | U-300 | Analogue | Pen | $400 to $600 (3 or 5 pens§) |
Ultra–long acting | ||||
Regular | U-500 | Human | Pen or vial | $600 (3 pens||) $1,500 (1 vial) |
Degludec (Tresiba Flextouch) | U-100 | Analogue | Pen | $450 (5 pens) |
Degludec | U-200 | Analogue | Pen | $575 (3 pens†) |
Premixed | ||||
70% isophane/30% regular (Humulin 70/30) | U-100 | Human | Pen or vial | $300 (3 pens) $50 (1 vial) |
70% isophane/30% regular (Novolin 70/30) | U-100 | Human | Vial | $165 (1 vial) |
70% aspart protamine/30% aspart (Novolog Mix 70/30) | U-100 | Analogue | Pen or vial | $550 (5 pens) $300 (1 vial) |
50% lispro protamine/50% lispro (Humalog Mix 50/50) | U-100 | Analogue | Pen or vial | $535 (5 pens) $290 (1 vial) |
75% lispro protamine/25% lispro (Humalog Mix 75/25) | U-100 | Analogue | Pen or vial | $320 (5 pens) $330 (1 vial) |
70% degludec/30% aspart (Ryzodeg) | U-100 | Analogue | Pen | Not yet available to pharmacies |